tiprankstipranks
Relay Therapeutics (RLAY)
NASDAQ:RLAY
US Market

Relay Therapeutics (RLAY) Financial Statements

274 Followers

Relay Therapeutics Financial Overview

Relay Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.793; its P/E ratio is -2.92; Relay Therapeutics is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-0.74. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 25.20M$ 119.00K$ 226.00K$ 253.00K$ 344.00K
Gross Profit$ 25.20M$ 119.00K$ 226.00K--
EBIT$ -68.13M$ -102.81M$ -101.18M$ -83.39M$ -82.63M
EBITDA$ -69.65M$ -103.68M$ -102.00M$ -82.23M$ -81.60M
Net Income Common Stockholders$ -68.13M$ -98.50M$ -94.24M$ -67.50M$ -84.17M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 151.33M$ 145.90M$ 161.28M$ 998.92M$ 1.05B
Total Assets$ 906.96M$ 962.02M$ 1.04B$ 1.10B$ 1.17B
Total Debt$ 54.60M$ 55.71M$ 56.75M$ 57.74M$ 60.28M
Net Debt$ -96.73M$ -90.19M$ -104.53M$ -941.17M$ -993.51M
Total Liabilities$ 128.59M$ 151.90M$ 154.15M$ 149.55M$ 168.95M
Stockholders Equity$ 778.37M$ 810.12M$ 883.41M$ 950.22M$ 999.77M
Cash Flow-
Free Cash Flow$ -75.99M$ -70.10M$ -69.05M$ -59.40M$ -68.24M
Operating Cash Flow$ -75.40M$ -68.60M$ -67.13M$ -57.08M$ -66.14M
Investing Cash Flow$ 71.36M$ 51.28M$ 75.31M$ -146.94M$ 27.19M
Financing Cash Flow$ 9.46M$ 2.08M$ 1.30M$ 1.17M$ 285.87M
Currency in USD

Relay Therapeutics Earnings and Revenue History

Relay Therapeutics Debt to Assets

Relay Therapeutics Cash Flow

Relay Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis